Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Deep brain stimulation for severe obsessive-compulsive disorder

Official title: Reclaim™ Deep Brain Stimulation (DBS) Therapy for Obsessive-Compulsive Disorder (OCD)

Run by Northwell Health · NCT02773082 · Data updated 2026-11-12

This study is testing if deep brain stimulation can help people with severe obsessive-compulsive disorder who haven't found relief from other treatments.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorNorthwell Health
Academic / other
Locations1 site (Queens, New York)
StatusRecruiting
StartedJuly 6, 2024
Main results expectedJanuary 1, 2030
Study endsJanuary 1, 2030
Registry record updatedOctober 29, 2025
Trial IDNCT02773082 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with a diagnosis of severe OCD lasting at least 5 years who have failed multiple treatment options.

Probably not a fit

Patients with primary hoarding disorder or those with serious comorbid psychiatric conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study explores the use of deep brain stimulation (DBS) as a treatment for patients with chronic, severe obsessive-compulsive disorder (OCD) who have not responded to traditional therapies such as medication and cognitive behavior therapy. The DBS procedure involves implanting a device that delivers electrical impulses to specific brain regions associated with mood and anxiety. Patients eligible for this intervention must have a long history of treatment-resistant OCD and meet specific medical criteria. The study aims to provide an alternative to irreversible neurosurgical procedures for these patients.

Why it matters

Potential benefit: If successful, this treatment could significantly improve the quality of life for patients suffering from severe, treatment-resistant OCD.

How similar studies have gone: While DBS has shown promise in treating other neurological conditions, its application for OCD is still relatively novel and has not been extensively tested in large-scale studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Have a diagnosis of OCD with a documented duration of at least 5 years
* Have OCD rated as severe or extreme illness
* Have failed to improve following treatment with at least 3 selective serotonin reuptake inhibitors (SSRIs) and clomipramine
* Do not have hoarding as their primary subclassification
* Have completed or tried to complete Exposure and Response Prevention Therapy (ERP)
* Have no serious psychiatric disorder in addition to OCD (e.g. comorbid personality disorder) or current substance abuse issues
* Meet established criteria for implantation of a deep brain stimulation system
* Are 18 years old or older
* Have not had a previous surgery to destroy the region of the brain that will be the target of stimulation
* Are not pregnant
* Have no other neurological disorders, including dementia
* Do not have a bleeding disorder or are not taking blood thinners
* Are capable of giving informed consent

Exclusion Criteria:

* Patients who are unable to properly operate the neurostimulator
* Patients who will be exposed to diathermy

Where it's running

  • Zucker Hillside Hospital
    Queens, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.